Abbott Laboratories (ABT) Debt Ratio (2009 - 2026)

Abbott Laboratories has disclosed Debt Ratio across 18 years of filings, most recently posting 0.31 for Q1 2026.

• Debt Ratio for Q1 2026 came in at 0.31, up 89.64% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.31 (up 89.64% YoY), and the FY2025 annual result was 0.15, down 14.06% from the prior year.
• Debt Ratio came in at 0.31 for Q1 2026 at Abbott Laboratories, up from 0.15 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 5.82 in Q4 2022 to a low of 0.15 in Q4 2025.
• The 5-year median for Debt Ratio is 0.2 (2024), against an average of 0.53.
• Across the five-year window, Debt Ratio surged 134.04% in 2022 and tumbled 96.55% in 2023, its largest moves.
• Abbott Laboratories' Debt Ratio stood at 5.82 in 2022, then sank by 96.55% to 0.2 in 2023, then decreased by 13.47% to 0.17 in 2024, then dropped by 14.06% to 0.15 in 2025, then surged by 106.78% to 0.31 in 2026.
• The last three Debt Ratio figures came in at 0.31 (Q1 2026), 0.15 (Q4 2025), and 0.15 (Q3 2025), per Business Quant data.